CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update – GlobeNewswire (press release)
|
CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company focused on creating transformative medicines for serious diseases, today announced financial results for … |
